Cargando…
Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice
INTRODUCTION: Respiratory tract infections are a worldwide health problem for humans and animals. Different cell types produce lipid mediators in response to infections, which consist of eicosanoids like hydroxyeicosatetraenoic acids (HETEs) or oxylipins like hydroxydocosahexaenoic acids (HDHAs). Bo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185708/ https://www.ncbi.nlm.nih.gov/pubmed/35687250 http://dx.doi.org/10.1007/s11306-022-01898-4 |
_version_ | 1784724777714319360 |
---|---|
author | Schultz, Daniel Cuypers, Fabian Skorka, Sebastian B. Rockstroh, Jan Gesell Salazar, Manuela Krieger, Jakob Albrecht, Dirk Völker, Uwe Hammerschmidt, Sven Lalk, Michael Siemens, Nikolai Methling, Karen |
author_facet | Schultz, Daniel Cuypers, Fabian Skorka, Sebastian B. Rockstroh, Jan Gesell Salazar, Manuela Krieger, Jakob Albrecht, Dirk Völker, Uwe Hammerschmidt, Sven Lalk, Michael Siemens, Nikolai Methling, Karen |
author_sort | Schultz, Daniel |
collection | PubMed |
description | INTRODUCTION: Respiratory tract infections are a worldwide health problem for humans and animals. Different cell types produce lipid mediators in response to infections, which consist of eicosanoids like hydroxyeicosatetraenoic acids (HETEs) or oxylipins like hydroxydocosahexaenoic acids (HDHAs). Both substance classes possess immunomodulatory functions. However, little is known about their role in respiratory infections. OBJECTIVES: Here, we aimed to analyze the lipid mediator imprint of different organs of C57BL/6J mice after intranasal mono-infections with Streptococcus pneumoniae (pneumococcus), Staphylococcus aureus or Influenza A virus (IAV) as wells as pneumococcal-IAV co-infection. METHODS: C57BL/6J mice were infected with different pathogens and lungs, spleen, and plasma were collected. Lipid mediators were analyzed using HPLC-MS/MS. In addition, spatial-distribution of sphingosine 1-phosphate (S1P) and ceramide 1-phosphates (C1P) in tissue samples was examined using MALDI-MS-Imaging. The presence of bacterial pathogens in the lung was confirmed via immunofluorescence staining. RESULTS: We found IAV specific changes for different HDHAs and HETEs in mouse lungs as well as enhanced levels of 20-HETE in severe S. aureus infection. Moreover, MALDI-MS-Imaging analysis showed an accumulation of C1P and a decrease of S1P during co-infection in lung and spleen. Long chain C1P was enriched in the red and not in the white pulp of the spleen. CONCLUSIONS: Lipid mediator analysis showed that host synthesis of bioactive lipids is in part specific for a certain pathogen, in particular for IAV infection. Furthermore, MS-Imaging displayed great potential to study infections and revealed changes of S1P and C1P in lungs and spleen of co-infected animals, which was not described before. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-022-01898-4. |
format | Online Article Text |
id | pubmed-9185708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-91857082022-06-10 Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice Schultz, Daniel Cuypers, Fabian Skorka, Sebastian B. Rockstroh, Jan Gesell Salazar, Manuela Krieger, Jakob Albrecht, Dirk Völker, Uwe Hammerschmidt, Sven Lalk, Michael Siemens, Nikolai Methling, Karen Metabolomics Original Article INTRODUCTION: Respiratory tract infections are a worldwide health problem for humans and animals. Different cell types produce lipid mediators in response to infections, which consist of eicosanoids like hydroxyeicosatetraenoic acids (HETEs) or oxylipins like hydroxydocosahexaenoic acids (HDHAs). Both substance classes possess immunomodulatory functions. However, little is known about their role in respiratory infections. OBJECTIVES: Here, we aimed to analyze the lipid mediator imprint of different organs of C57BL/6J mice after intranasal mono-infections with Streptococcus pneumoniae (pneumococcus), Staphylococcus aureus or Influenza A virus (IAV) as wells as pneumococcal-IAV co-infection. METHODS: C57BL/6J mice were infected with different pathogens and lungs, spleen, and plasma were collected. Lipid mediators were analyzed using HPLC-MS/MS. In addition, spatial-distribution of sphingosine 1-phosphate (S1P) and ceramide 1-phosphates (C1P) in tissue samples was examined using MALDI-MS-Imaging. The presence of bacterial pathogens in the lung was confirmed via immunofluorescence staining. RESULTS: We found IAV specific changes for different HDHAs and HETEs in mouse lungs as well as enhanced levels of 20-HETE in severe S. aureus infection. Moreover, MALDI-MS-Imaging analysis showed an accumulation of C1P and a decrease of S1P during co-infection in lung and spleen. Long chain C1P was enriched in the red and not in the white pulp of the spleen. CONCLUSIONS: Lipid mediator analysis showed that host synthesis of bioactive lipids is in part specific for a certain pathogen, in particular for IAV infection. Furthermore, MS-Imaging displayed great potential to study infections and revealed changes of S1P and C1P in lungs and spleen of co-infected animals, which was not described before. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-022-01898-4. Springer US 2022-06-10 2022 /pmc/articles/PMC9185708/ /pubmed/35687250 http://dx.doi.org/10.1007/s11306-022-01898-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Schultz, Daniel Cuypers, Fabian Skorka, Sebastian B. Rockstroh, Jan Gesell Salazar, Manuela Krieger, Jakob Albrecht, Dirk Völker, Uwe Hammerschmidt, Sven Lalk, Michael Siemens, Nikolai Methling, Karen Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
title | Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
title_full | Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
title_fullStr | Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
title_full_unstemmed | Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
title_short | Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
title_sort | bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185708/ https://www.ncbi.nlm.nih.gov/pubmed/35687250 http://dx.doi.org/10.1007/s11306-022-01898-4 |
work_keys_str_mv | AT schultzdaniel bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT cuypersfabian bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT skorkasebastianb bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT rockstrohjan bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT gesellsalazarmanuela bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT kriegerjakob bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT albrechtdirk bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT volkeruwe bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT hammerschmidtsven bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT lalkmichael bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT siemensnikolai bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice AT methlingkaren bioactivelipidscreeningduringrespiratorytractinfectionswithbacterialandviralpathogensinmice |